# Myovant Sciences Ltd.

Myovant Sciences Ltd. is a company headquartered in London, United Kingdom.

## Company overview

- **Legal name:** Myovant Sciences Ltd.
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** London, United Kingdom
- **Incorporated in:** CA
- **Fiscal year end:** March 31
- **SEC CIK:** 0001679082

## About

Myovant Sciences Ltd. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001679082, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2022-05-11, it reported annual revenue of USD 230,972,000; net income of USD -205,981,000; total assets of USD 520,011,000 for the fiscal period ended 2022-03-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2022 (period ended 2022-03-31)

- **Revenue:** $231.0M (USD 230,972,000)
- **Net income:** -$206.0M (USD -205,981,000)
- **Total assets:** $520.0M (USD 520,011,000)
- **Cash and equivalents:** $406.7M (USD 406,704,000)
- **Operating cash flow:** -$268.6M (USD -268,559,000)

### FY2021 (period ended 2021-03-31)

- **Revenue:** $59.3M (USD 59,317,000)
- **Net income:** -$255.1M (USD -255,134,000)
- **Total assets:** $725.0M (USD 725,027,000)
- **Cash and equivalents:** $674.5M (USD 674,493,000)
- **Operating cash flow:** $370.6M (USD 370,628,000)

### FY2020 (period ended 2020-03-31)

- **Net income:** -$289.0M (USD -288,989,000)
- **Total assets:** $105.9M (USD 105,926,000)
- **Cash and equivalents:** $76.6M (USD 76,644,000)
- **Operating cash flow:** -$221.2M (USD -221,172,000)

### FY2019 (period ended 2019-03-31)

- **Net income:** -$273.6M (USD -273,551,000)
- **Total assets:** $173.0M (USD 172,977,000)
- **Cash and equivalents:** $156.1M (USD 156,074,000)
- **Operating cash flow:** -$224.1M (USD -224,088,000)

## Recent SEC filings

- Form 8-K — filed 2023-03-10 — period 2023-03-10 — 8-K
- Form 8-K — filed 2023-03-01 — period 2023-03-01 — 8-K
- Form SC 13G — filed 2023-02-17 — SCHEDULE 13G
- Form SC 13G — filed 2023-02-09
- Form 10-Q — filed 2023-01-26 — period 2022-12-31 — 10-Q
- Form 8-K — filed 2023-01-26 — period 2023-01-26 — 8-K
- Form 10-Q — filed 2022-10-26 — period 2022-09-30 — 10-Q
- Form 8-K — filed 2022-10-26 — period 2022-10-26 — 8-K
- Form 8-K — filed 2022-10-24 — period 2022-10-23 — FORM 8-K
- Form 8-K — filed 2022-10-21 — period 2022-10-21 — 8-K
- Form 8-K — filed 2022-10-03 — period 2022-09-30 — 8-K
- Form DEF 14A — filed 2022-07-28 — period 2022-10-21 — DEF 14A

---

Updated: 2026-10-23T20:06:36Z

Canonical page: https://altss.com/profile/myovant-sciences-ltd

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology